罗孚兄弟。
The brothers RAF.
机构信息
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
出版信息
Cell. 2010 Jan 22;140(2):180-2. doi: 10.1016/j.cell.2010.01.013.
PMID:20141832
Abstract
Targeted molecular therapies for cancer treatment have shown promise, but also have limitations. In this issue, Heidorn et al. (2010) find that a class of targeted molecular therapies with clinical effectiveness against one melanoma subtype may have adverse clinical effects in another.
摘要
针对癌症治疗的靶向分子疗法显示出了前景，但也存在局限性。在本期杂志中，Heidorn 等人（2010）发现，一类针对一种黑色素瘤亚型具有临床疗效的靶向分子疗法，可能在另一种亚型中具有不良的临床效果。
Zotero 插件